等待开盘 11-07 09:30:00 美东时间
-0.910
-4.57%
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
11-05 10:35
今日重点评级关注:HC Wainwright & Co.:维持Unicycive Therapeutics"买入"评级,目标价从9美元升至22美元;花旗:维持Arcus Biosciences"买入"评级,目标价从54美元升至56美元
10-30 14:22
Truist Securities analyst Barry Jonas maintains Caesars Entertainment (NASDAQ:CZR) with a Buy and lowers the price target from $32 to $30.
10-29 23:07
凯撒娱乐(Caesars Entertainment,CZR)股价大跌11.8%,尽管该公司此前报告第三季度业绩强劲,净营收达29亿美元,但仍未能阻止股价走...
10-29 22:17
Caesars Entertainment (NASDAQ:CZR) fell in early trading on Wednesday after falling short of estimates with its third-quarter earnings report. Revenue was flat compared to a year ago at $2.87 billion....
10-29 19:14
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Caesars Entertainment 2025年第三季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体业绩表现:** - 合并净收入:29亿美元 - 调整后EBITDAR:8.84亿美元 - 持有率标准化调整后EBITDAR:9.27亿美元 **分业务板块表现:** - 拉斯维加斯业务:调整后EBITDAR为3.79亿美元,持有率标准化后为3.98亿美元 - 区域业务:调整后EBITDA为5.06亿美元,净收入同比增长6% - 数字业务:净收入3.11亿美元,调整后EBITDA为2800万美元 ## 2. 财务指标变化
10-29 12:16
10月29日,凯撒娱乐盘后股价跌超6%!公布的第三季度业绩未能达到分析师预期。这家赌场运营商报告的亏损超出预期,主要因为其拉斯维加斯业务和数字博彩部门表现不佳...
10-29 06:55
Gainers Educational Development (NASDAQ:EDUC) shares rose 35.6% to $2.02 durin...
10-29 05:13
Here's a look at the details from the Caesars Entertainment Q3 earnings report.
10-29 04:53
Caesars Entertainment (NASDAQ:CZR) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $0.01 by 2554.55 percent. This is a 575 percent decrease over losses of $(0.04) per share
10-29 04:13